Navigation Links
NeurogesX Reports First Quarter 2009 Results
Date:5/7/2009

United States.

Net loss for the first quarter of 2009 was approximately $4.6 million, compared to a net loss of approximately $8.0 million for the first quarter of 2008. Net loss per share attributable to common stockholders was $0.26 per share and $0.46 per share for the three months ended March 31, 2009 and 2008, respectively, based on weighted average shares outstanding of 17,568,600 and 17,468,395 respectively.

Cash, cash equivalents and short-term investments were approximately $18.8 million at March 31, 2009, compared to $24.5 million at December 31, 2008.

Stephen Ghiglieri, CFO, commented, "We have focused our cash resources to prosecute our MAA and NDA for Qutenza and to support strategies for obtaining adequate reimbursement for Qutenza in the United States, while deferring further clinical development of Qutenza, NGX-1998 and our preclinical prodrug development programs. As a result of our conservative cost management strategy, we believe that our cash runway is sufficient to last at least until December 31, 2009. Potential near-term proceeds from a European commercial partnership, which we expect to finalize in the first half of 2009, would provide additional runway and have not been accounted for in our current cash forecast. As we pursue European and U.S. commercial partnerships, and other non-equity based sources of funding, we do not currently intend to raise equity capital in the public markets at our present valuation."

Development Update

Currently, NeurogesX is primarily focused on completing the development through regulatory approval, of Qutenza for patients with PHN in the United States and for peripheral neuropathic pain in non-diabetic adults in the E.U.

The CHMP's positive opinion recommending E.U. approval of Qutenza for the treatment of peripheral neuropathic pain in non-diabetic adults, either alone or in combination wi
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. NeurogesX to Hold Conference Call to Discuss First Quarter 2009 Financial Results
2. NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting
3. NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update
4. NeurogesX Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
5. NeurogesX to Present at 11th Annual BIO CEO & Investor Conference
6. NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference
7. NeurogesX Reports Third Quarter 2008 Results
8. NeurogesX to Report Third Quarter 2008 Financial Results
9. NeurogesX Submits NDA for NGX-4010 Dermal Capsaicin Patch for Treatment of Postherpetic Neuralgia (PHN)
10. NeurogesX Responds to EMEAs Day 120 Questions
11. NeurogesX to Present at Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Research and Markets ( ... "Biopreservation Market by Product, Biospecimen, Application and ... report to their offering. The global ... Million by 2020 from USD 2,150.48 Million in ... 2015 and 2020. Biopreservation ensures the ...
(Date:9/3/2015)... ... September 03, 2015 , ... The latest addition to the Mettler-Toledo PCE ... labels automatically. Companies in the pharmaceutical and healthcare industry can use the LSS to ... minute. The Label Serialization Station can be fully integrated into the production line and ...
(Date:9/3/2015)... Sept. 3, 2015  Vermillion, Inc. (NASDAQ: VRML ... today announced that Herbert Fritsche , Ph.D., the ... is the recipient of the 2015 Abbott Award, given ... for outstanding contributions to the field of basic or ... October 5 th in Zakopane, Poland ...
(Date:9/3/2015)... , September 3, 2015 ... Market by System (LC (HPLC, UHPLC, Flash), GC, Other ... Columns, Syringe Filters, Vials) - Analysis & Global Forecasts ... is expected to reach around 9.223 Billion by 2020 ... of 5.5%. Browse 141 tables and 36 ...
Breaking Biology Technology:Global Biopreservation Market 2015-2020 - Product, Biospecimen, Application and End User Analysis of the $3.73 Billion Industry 2Global Biopreservation Market 2015-2020 - Product, Biospecimen, Application and End User Analysis of the $3.73 Billion Industry 3Print and Verify Labels On The Production Line With New Label Serialization Stations 2Print and Verify Labels On The Production Line With New Label Serialization Stations 3Vermillion Announces Dr. Herbert Fritsche as Recipient of the 2015 Abbott Award from the International Society of Oncology and Biomarkers 2Chromatography Instruments Market Worth $ 9.223 Billion by 2020 2Chromatography Instruments Market Worth $ 9.223 Billion by 2020 3Chromatography Instruments Market Worth $ 9.223 Billion by 2020 4
... Inc. (OTC:,NNLX) a nano-biotechnology company announces that ... articles on the NanoLogix hydrogen,bioreactor technology under ... produced by Lisa Ann Pinkerton under the ... on various affiliated NPR stations,February 4th. The ...
... in Prostate, Lung and Brain Tumor ... ... a global leader in the field of radiosurgery,today announced key clinical presentation ... 2008 in,Scottsdale, Ariz., At this year,s CyberKnife Users, meeting eight presentations ...
... RDEA ) today announced that Barry D. Quart, PharmD, ... Capital Partners,20th Annual OC Growth Stock Conference., ... Pacific Time Location: The Ritz Carlton Laguna Niguel, ... http://www.ardeabio.com About Ardea Biosciences, ...
Cached Biology Technology:National Public Radio (NPR) Features Broadcast Articles on NanoLogix Hydrogen Bioreactor Operation at Welch's Foods 2CyberKnife Users' Meeting Highlights Major Clinical Data Milestones and Emerging Trends 2CyberKnife Users' Meeting Highlights Major Clinical Data Milestones and Emerging Trends 3CyberKnife Users' Meeting Highlights Major Clinical Data Milestones and Emerging Trends 4Ardea Biosciences to Present at Roth Capital Partners' 20th Annual OC Growth Stock Conference 2
(Date:8/18/2015)... 2015  Navitas today announced that it ... Submission Content Management webinar scheduled on August ... to the Implementation of Regulatory Submission Standards ... industry, vendors, health authorities, consultants and the ... a standard method of implementing electronic submission ...
(Date:8/12/2015)... SPRINGS, Florida , August 12, 2015 ... the pace of mobile payment innovation and advanced biometrics ... to replace the way consumers rely on using their ... ahead with reinventing the future for payment services led ... (NASDAQ: NXTD ), :  Google, Inc. (NASDAQ: ...
(Date:8/10/2015)... , August 10, 2015 ... Eye Tracking Technology for more than two decades, announces ... for integration into all consumer display formats. The SMI ... integration of eye tracking into consumer tablets, laptops, desktop ... smart glasses. Omnivision,s leading sensor technology contributes to the ...
Breaking Biology News(10 mins):Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3
... in German . , More and more ... longer be combated. The World Health Organization WHO is warning ... WHO,s director-general Margaret Chan has pointed out that if measures ... to treat many frequently occurring infections. Figures released by the ...
... how to prime a second arm of the immune ... of two adjuvants, chemicals used to boost the effectiveness ... to join antibodies in response to influenza infection. Since ... that does not change from year to year, the ...
... SCOTTSDALE, Ariz. June 8, 2011 Dr. ... Genomics Research Institute (TGen) and at the Virginia G. ... Chief Medical Officer of an international lung cancer research ... the Cancer Research and Biostatistics-Clinical Trials Consortium (CRAB-CTC), a ...
Cached Biology News:An alternative to antibiotics 2Adjuvant combo shows potential for universal influenza vaccine 2TGen, Virginia G. Piper Cancer Center scientist heads lung cancer consortium 2
... PCRx Enhancer System is ... polymerases to optimize PCR of ... 10X PCRX Enhancer Solution with ... higher primer specificity broader magnesium ...
Mouse Exodus 2 - 12kDa...
Laminin gamma-2 (G-16)...
Fluorescein-CSCSSLMDKECVYFCHLDIIW (Disulfide bridge: 1-15 and 3-11)...
Biology Products: